Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Inhibikase Therapeutics, Inc. IKT

Set alert

Price alert · IKT

All alert types
1.54 USD -0.01 -0.65%

At close · Nov 2

1.54 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
1.53 × 2
Ask
1.54 × 2
1.47 Day range 1.59
1.33 52-week range 2.61
YTD
-24.88%
1 year
+4.76%
Open
1.56
Prev close
1.55
Mkt cap
214.89M
Vol
449.23K
Avg vol
575.16K
EPS
-0.43
P/E
0.00
Div yield
0.00%
More statistics
Low
1.47
High
1.59
Forward P/E
-11.84
Beta
1.12
Short ratio
0.17
Inst. own
11.62%
Dividend
0.00
Ex-div date
Earnings
Aug 14, 2024
50-d avg
2.62
200-d avg
1.84
1y target
7.00

5D chart

Chart tools
Interval
1m5m15m30m

Signals (47)
NameTimeAgo
MACD: Sell SignalNov 2, 10:15 AM6 hours ago
SMA: BearishNov 2, 9:40 AM7 hours ago
SMA: BearishNov 2, 9:40 AM7 hours ago
SMA: BullishNov 2, 9:30 AM7 hours ago
SMA: BullishNov 2, 9:30 AM7 hours ago
MACD: Buy SignalOct 30, 3:10 PM3 days ago
MACD: Sell SignalOct 30, 2:20 PM3 days ago
RSI: OversoldOct 30, 2:10 PM3 days ago
MACD: Buy SignalOct 30, 1:00 PM3 days ago
RSI: OversoldOct 30, 12:45 PM3 days ago
RSI: OversoldOct 30, 12:10 PM3 days ago
MACD: Sell SignalOct 30, 11:35 AM3 days ago
RSI: OversoldOct 30, 11:35 AM3 days ago
SMA: BearishOct 30, 11:20 AM3 days ago
MACD: Buy SignalOct 30, 10:45 AM3 days ago
SMA: BullishOct 30, 10:40 AM3 days ago
MACD: Sell SignalOct 30, 9:45 AM3 days ago
SMA: BearishOct 30, 9:40 AM3 days ago
MACD: Buy SignalOct 29, 3:30 PM4 days ago
MACD: Sell SignalOct 29, 3:15 PM4 days ago
MACD: Buy SignalOct 29, 3:10 PM4 days ago
RSI: OversoldOct 29, 2:35 PM4 days ago
SMA: BearishOct 29, 11:45 AM4 days ago
SMA: BearishOct 29, 11:45 AM4 days ago
MACD: Sell SignalOct 29, 10:40 AM4 days ago
RSI: OverboughtOct 29, 9:30 AM4 days ago
MACD: Buy SignalOct 28, 3:05 PM5 days ago
MACD: Sell SignalOct 28, 3:00 PM5 days ago
MACD: Buy SignalOct 28, 2:45 PM5 days ago
MACD: Sell SignalOct 28, 12:20 PM5 days ago
RSI: OverboughtOct 28, 11:55 AM5 days ago
MACD: Buy SignalOct 28, 10:40 AM5 days ago
MACD: Sell SignalOct 28, 10:30 AM5 days ago
SMA: BearishOct 28, 10:25 AM5 days ago
MACD: Buy SignalOct 28, 10:10 AM5 days ago
SMA: BullishOct 28, 10:05 AM5 days ago
SMA: BullishOct 28, 10:05 AM5 days ago
MACD: Sell SignalOct 27, 3:30 PM6 days ago
MACD: Buy SignalOct 27, 2:40 PM6 days ago
MACD: Sell SignalOct 27, 2:35 PM6 days ago
MACD: Buy SignalOct 27, 2:00 PM6 days ago
SMA: BearishOct 27, 1:45 PM6 days ago
MACD: Sell SignalOct 27, 1:45 PM6 days ago
MACD: Buy SignalOct 27, 1:40 PM6 days ago
SMA: BearishOct 27, 12:40 PM6 days ago
MACD: Sell SignalOct 27, 12:35 PM6 days ago
RSI: OverboughtOct 27, 12:05 PM6 days ago

Financial health

Altman Z-Score

10.98 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 4
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 3

Valuation

P/E -4.2×
FY 2016: -124×FY 2017: -238×FY 2018: -36.9×FY 2019: -17.8×FY 2020: -24.1×FY 2021: -1.8×FY 2022: -0.7×FY 2023: -0.4×FY 2024: -2.8×FY 2025: -4.2×
FY 2016 5y median -1.8× FY 2025
P/S 0.0×
FY 2016: 79.8×FY 2017: 49.6×FY 2018: 19.6×FY 2019: 91.0×FY 2020: 99.3×FY 2021: 8.6×FY 2022: 102×FY 2023: 26.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 8.6× FY 2025
P/B 1.2×
FY 2016: -57.1×FY 2017: -70.9×FY 2018: -102×FY 2019: -22.8×FY 2020: 7.1×FY 2021: 0.7×FY 2022: 0.6×FY 2023: 0.6×FY 2024: 0.8×FY 2025: 1.2×
FY 2016 5y median 0.7× FY 2025
P/FCF -7.3×
FY 2016: -2610×FY 2017: -808×FY 2018: 111×FY 2019: -302×FY 2020: -61.4×FY 2021: -1.9×FY 2022: -0.7×FY 2023: -0.4×FY 2024: -4.0×FY 2025: -7.3×
FY 2016 5y median -1.9× FY 2025
EV/EBITDA -1.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -0.3×FY 2023: 0.1×FY 2024: -0.8×FY 2025: -1.2×
FY 2016 5y median -0.3× FY 2025
EV/Sales 0.0×
FY 2016: 80.1×FY 2017: 49.8×FY 2018: 19.6×FY 2019: 91.3×FY 2020: 79.8×FY 2021: -4.4×FY 2022: 46.7×FY 2023: -6.8×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -13.8%
FY 2016: -0.0%FY 2017: -0.1%FY 2018: 0.9%FY 2019: -0.3%FY 2020: -1.6%FY 2021: -53.4%FY 2022: -139.6%FY 2023: -267.2%FY 2024: -24.8%FY 2025: -13.8%
FY 2016 5y median -53.4% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 12.5%FY 2017: 14.8%FY 2018: 9.7%FY 2019: -127.4%FY 2020: -28.0%FY 2021: -266.4%FY 2022: 94.6%FY 2023: -5127.8%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: -63.4%FY 2017: -19.7%FY 2018: -52.5%FY 2019: -507.5%FY 2020: -403.5%FY 2021: -476.2%FY 2022: -14686.2%FY 2023: -7712.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median -476.2% FY 2025
Net Margin 0.0%
FY 2016: -65.0%FY 2017: -21.2%FY 2018: -53.3%FY 2019: -509.7%FY 2020: -407.7%FY 2021: -476.9%FY 2022: -14625.9%FY 2023: -7304.8%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median -476.9% FY 2025
ROE -27.9%
FY 2016: 46.5%FY 2017: 30.3%FY 2018: 276.7%FY 2019: 127.5%FY 2020: -29.1%FY 2021: -38.5%FY 2022: -85.8%FY 2023: -173.3%FY 2024: -29.0%FY 2025: -27.9%
FY 2016 5y median -38.5% FY 2025
ROIC -30.1%
FY 2016: 60.0%FY 2017: 41.3%FY 2018: 389.9%FY 2019: 138.4%FY 2020: -27.9%FY 2021: -38.2%FY 2022: -84.8%FY 2023: -173.2%FY 2024: -30.1%FY 2025: -30.1%
FY 2016 5y median -38.2% FY 2025
ROA -26.6%
FY 2016: -385.9%FY 2017: -152.9%FY 2018: -75.6%FY 2019: -14960.5%FY 2020: -19.3%FY 2021: -34.8%FY 2022: -72.4%FY 2023: -131.2%FY 2024: -27.9%FY 2025: -26.6%
FY 2016 5y median -34.8% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 113.0%FY 2018: 96.1%FY 2019: -72.2%FY 2020: -37.8%FY 2021: 343.9%FY 2022: -96.0%FY 2023: 111.0%FY 2024: -100.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -81.8%
FY 2016: 0.0%FY 2017: 33.9%FY 2018: -423.8%FY 2019: -168.5%FY 2020: 50.5%FY 2021: -423.9%FY 2022: -22.8%FY 2023: -10.8%FY 2024: -42.3%FY 2025: -81.8%
FY 2016 FY 2025
EPS (diluted) 57.8%
FY 2016: 0.0%FY 2017: 47.9%FY 2018: -544.0%FY 2019: -107.5%FY 2020: 48.5%FY 2021: -183.7%FY 2022: 12.7%FY 2023: 16.2%FY 2024: 67.5%FY 2025: 57.8%
FY 2016 FY 2025
Free Cash Flow -45.1%
FY 2016: 0.0%FY 2017: -327.4%FY 2018: 665.7%FY 2019: -147.3%FY 2020: -233.8%FY 2021: -1165.9%FY 2022: -23.1%FY 2023: -2.9%FY 2024: -5.8%FY 2025: -45.1%
FY 2016 FY 2025

Financial Health

Current Ratio 21.7×
FY 2016: 0.1×FY 2017: 0.1×FY 2018: 0.3×FY 2019: 0.0×FY 2020: 3.1×FY 2021: 10.5×FY 2022: 6.6×FY 2023: 4.1×FY 2024: 26.4×FY 2025: 21.7×
FY 2016 5y median 10.5× FY 2025
Quick Ratio 21.7×
FY 2016: 0.1×FY 2017: 0.1×FY 2018: 0.3×FY 2019: 0.0×FY 2020: 3.1×FY 2021: 10.5×FY 2022: 6.6×FY 2023: 4.1×FY 2024: 26.4×FY 2025: 21.7×
FY 2016 5y median 10.5× FY 2025
Debt / Equity 0.0×
FY 2016: -0.2×FY 2017: -0.3×FY 2018: -0.3×FY 2019: -0.1×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.1×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 2.6×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.4×FY 2023: 0.5×FY 2024: 2.1×FY 2025: 2.6×
FY 2016 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: -70.0×FY 2019: -229×FY 2020: -95.9×FY 2021: -741×FY 2022: -243×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31